Loading clinical trials...
Loading clinical trials...
Effectiveness of Lacticaseibacillus Rhamnosus LRa05 in Alleviating Allergic Rhinitis and Its Impact on Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled Trial
Conditions
Interventions
probiotic product
Maltodextrin
Locations
1
China
Qilu Hospital of Shangdong University
Jinan, Shangdong, China
Start Date
December 1, 2024
Primary Completion Date
November 1, 2025
Completion Date
December 1, 2025
Last Updated
November 21, 2024
Lead Sponsor
Wecare Probiotics Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions